10-K: LanzaTech Faces Going Concern Doubt Amidst Losses, Seeks Capital

LanzaTech Global, Inc. reported a reduced net loss in 2025 but disclosed substantial doubt about its ability to continue as a going concern, necessitating significant future financing.

Summary

• Net loss significantly decreased to $(48.9) million in 2025 from $(137.7) million in 2024.
• Total revenue increased by 12.6% to $55.8 million in 2025, driven by licensing revenue from LanzaJet and CarbonSmart product sales.
• Recurring revenue, including licensing and sales of microbes and media, grew by 79% to $20.9 million in 2025.
• Research and Development (R&D) expenses decreased by 30.9% to $53.2 million in 2025, reflecting cost optimization efforts.
• Selling, General and Administrative (SG&A) expenses decreased by 5.9% to $47.0 million in 2025.
• The company had cash and cash equivalents of $13.2 million as of December 31, 2025, a 62.7% decrease from the prior year.
• An accumulated deficit of $(1,018.6) million was reported as of December 31, 2025.
• Management concluded there is substantial doubt about the company's ability to continue as a going concern due to recurring losses and insufficient liquidity.
• A private placement in January 2026 raised $20.0 million in gross proceeds through the issuance of 4,000,000 common shares and 510,968 bonus shares.
• The PIPE Warrant, issued in May 2025, allows the purchase of 7,800,000 common shares at a nominal exercise price, exercisable until December 31, 2026.
• LanzaTech's ownership interest in LanzaJet decreased to approximately 45.6% on a fully diluted basis following a Series A transaction in February 2026.
• The LanzaJet Note Purchase Agreement was amended in February 2026 to defer principal payments until June 30, 2027.
• Six commercial plants utilizing LanzaTech's technology have produced over 139 million gallons of fuel-grade ethanol globally.
• The company implemented a 1-for-100 reverse stock split effective August 18, 2025, to regain Nasdaq compliance.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a challenging financial report, primarily due to the explicit 'going concern' warning and significant accumulated deficit, despite some positive operational improvements and recent capital raises. The ongoing need for substantial financing and internal control weaknesses temper optimism.

Positives

• Net loss significantly reduced from $(137.7) million in 2024 to $(48.9) million in 2025, representing a 64% improvement.
• Total revenue increased by 12.6% to $55.8 million in 2025, indicating growth in commercial activities.
• Recurring revenue from licensing and sales of microbes and media surged by 79% to $20.9 million in 2025, highlighting a positive shift in business model.
• R&D expense decreased by 30.9% ($23.8 million reduction) and SG&A expense decreased by 5.9% ($2.9 million reduction), demonstrating successful cost optimization and organizational streamlining.
• Six commercial plants are deployed and operational, having produced over 139 million gallons of fuel-grade ethanol, validating the technology's commercial viability.
• The Brookfield Loan maturity date was extended from October 3, 2027, to December 3, 2029, providing more financial flexibility.
• LanzaJet Note principal payments were deferred until June 30, 2027, easing short-term cash obligations for the investee.
• A private placement in January 2026 successfully raised $20.0 million in gross proceeds, providing additional capital.
• The Series A Convertible Senior Preferred Stock automatically converted into common stock, eliminating mandatory redemption provisions and simplifying the capital structure.
• Favorable resolution of significant legal proceedings, including the FPA litigation and Convertible Note litigation, reducing contingent liabilities and legal expenses.

Negatives

• Substantial doubt exists about the company's ability to continue as a going concern due to recurring net losses and insufficient liquidity to fund operations for the next 12 months.
• Cash and cash equivalents decreased by 62.7% from $43.5 million in 2024 to $13.2 million in 2025.
• The company reported a significant accumulated deficit of $(1,018.6) million as of December 31, 2025.
• Cash outflows from operating activities were $(64.9) million in 2025.
• Identified material weaknesses in internal control over financial reporting related to complex transactions, significant estimates, revenue recognition, and temporary capacity constraints in the finance organization, which have not yet been remediated.
• The exercise of the PIPE Warrant could result in significant dilution to stockholders, increasing outstanding shares by 77.3%.
• Share ownership is highly concentrated, with Khosla Ventures and its affiliates potentially owning 62.9% and, with January 2026 investors, collectively owning approximately 88.1% of outstanding common stock, which could limit trading activity.
• LanzaTech's ownership interest in LanzaJet decreased from 53.16% to 45.6% on a fully diluted basis, reducing its control over the SAF company.
• The company relies on a limited number of industry partners for a significant portion of its near-term revenue, with the largest contracting entity accounting for 37% of 2025 revenue.
• The market price of the company's common stock may be volatile, and there is a risk of delisting from Nasdaq if continued listing requirements are not met.

Risks

• There is substantial doubt about the company's ability to continue as a going concern.
• Substantial additional financing is required to fund operations, which may result in restrictions or significant dilution to stockholders and might not be available on acceptable terms.
• The company has incurred and anticipates continuing to incur losses, and has not yet generated material revenues from new business lines.
• Failure to successfully scale the cohort-based commercialization model, which is central to the long-term strategy.
• The success of partner plant operations is significantly dependent upon strong execution by respective industry partners, and failure to maintain these relationships could prevent profitability.
• Fluctuations in prices and availability of waste-based feedstocks may affect cost structure, gross margin, and ability to compete.
• The industry is characterized by rapidly advancing technologies, intense competition, and a complex intellectual property landscape, posing risks to market share.
• Adoption of process technologies by industry partners may be delayed or reduced due to customer qualification, negative life cycle assessment, or capital investment procedures.
• Failure of LanzaJet to successfully complete, commission, scale, and operate its initial facility or failure of third parties to adopt the LanzaJet process may severely impact business.
• Governmental programs incentivizing low-carbon fuels and carbon capture may not include LanzaTech's technology or could be repealed, curtailed, or changed.
• Inability to scale fast enough to reach profitability levels sufficient to generate a return on investment.
• Waste-based and other feedstocks may be used in alternative processes, restricting LanzaTech's addressable market.
• Significant disruption in information technology systems, including security breaches, or failure to implement new systems successfully, could adversely affect business operations.
• Political and economic uncertainty, including tariffs and changes in Chinese government policies or relations between China and the United States, may impact revenue and operations.
• Ability to operate in China may be impaired by changes in Chinese laws and regulations, including those relating to taxation, environmental regulation, and foreign investment.
• Operations and financial results may be impacted if the Chinese government determines the Shougang Joint Venture VIE structure does not comply with Chinese regulations.
• Subject to regulatory actions by the Chinese government targeting data security and monopolistic behavior.
• Changes in China's economic, political, or social conditions or legal system could have a material adverse effect on business.
• Risk that the Chinese government may intervene or influence operations at any time.
• An extended U.S. Government shutdown could materially adversely affect business, results of operations, and financial condition.
• Market prices for waste-based products are subject to volatility, and there is a limited referenceable market for such products.
• Patent rights and trade secret protections may not provide commercially meaningful protection against competition, and the company may not be able to operate without infringing third-party rights.
• Failure to maintain compliance with Nasdaq continued listing requirements could lead to delisting, negatively impacting price and liquidity.
• Stockholders will experience substantial dilution from the exercise of the PIPE Warrant and any additional equity financing.
• Concentrated share ownership could further limit trading activity.
• Khosla Ventures and its affiliates have significant influence, and their interests may conflict with other stockholders.
• A substantial portion of total outstanding shares may be sold into the market at any time, causing price drops.
• Reports by analysts that differ from actual results could adversely affect stock price and trading volume.
• Issuance of additional shares of common stock or other equity securities without stockholder approval would dilute ownership interests.
• No anticipated cash dividends on common stock in the foreseeable future.
• Public Warrants are identical to IPO Private Placement Warrants in material terms, except in certain circumstances, and materially different from other warrants.
• The company may redeem Public Warrants prior to their exercise at a time disadvantageous to holders.
• Public Warrants may only be exercisable on a cashless basis under certain circumstances, resulting in fewer shares.
• The Public Warrant Agreement designates specific courts as the sole and exclusive forum for certain actions, limiting holders' ability to choose a favorable judicial forum.
• Terms of the Public Warrants may be amended in a manner adverse to holders with the approval of at least 50% of outstanding Public Warrants.
• Identified deficiencies in internal control over financial reporting constitute material weaknesses, which, if not remediated, could affect accurate financial reporting or fraud prevention.
• Delaware law and provisions in the certificate of incorporation and bylaws could make a takeover proposal more difficult.
• The certificate of incorporation designates specific courts as the sole and exclusive forum for certain types of actions and proceedings, limiting stockholders' ability to choose a favorable judicial forum.

Future Outlook

LanzaTech is focused on streamlining core operations from R&D to global technology deployment, enhancing capital efficiency, and accelerating platform technology deployment. The company is shifting towards a cohort-based commercialization model to de-risk execution, align resources, and build revenue visibility. Anticipated near-term revenue remains linked to U.S. government programs, with potential delays from funding disruptions. Scaling the commercialization model depends on continued access to capital, disciplined project selection, and effective coordination across technical, regulatory, and financing workstreams. The company is actively pursuing capital raising, partnership, or asset-related opportunities, and other strategic options to enhance liquidity.

Management Comments

• "LanzaTech is focused on shifting its core operations from research and development to globally deploying the Companys proven technology."
• "We are streamlining our priorities to sharpen our business focus and improve our cost structure and evaluating other liquidity enhancing initiatives, including pursuing capital raising, partnership or asset-related opportunities, and other strategic options."
• "Management has concluded that our ability to continue as a going concern is dependent on our ability to execute our business plan, raise significant amounts of additional capital and/or implement other strategic options."

Industry Context

StockSavvy.ai notes that LanzaTech operates in the rapidly evolving carbon management and sustainable fuels industry, where technological advancements and supportive governmental policies (like tax incentives for low-carbon fuels) are key drivers. The company's focus on gas fermentation and waste-to-ethanol/SAF positions it to capitalize on the growing demand for circular carbon economy solutions, competing with traditional fossil fuel production and other emerging clean energy technologies. The strategic spin-off of LanzaJet and joint offerings like CirculAir reflect a trend towards integrated solutions in the SAF market, addressing increasing global demand for decarbonization in hard-to-abate sectors like aviation and heavy industry.

Comparison to Industry Standards

• LanzaTech's technology has been deployed at six commercial plants, producing over 139 million gallons of fuel-grade ethanol, demonstrating a proven commercial scale in the waste-to-ethanol sector.
• The LanzaJet Alcohol-to-Jet (ATJ) process, developed with the Pacific Northwest National Lab and the U.S. Department of Energy, first converted ethanol from steel mill emissions into SAF for Virgin Atlantic (2018) and All Nippon Airways (2019) flights, showcasing early adoption by major airlines and government collaboration.
• DAC CO2 to SAF is estimated to have a 94% emissions reduction when compared to the fossil counterpart at 94 g-CO2e/MJ of ATJ-SPK, positioning LanzaTech's integrated solutions favorably against conventional fossil fuels in terms of carbon intensity.
• The company's proprietary system is noted for producing multiple chemicals from diverse feedstocks using a single process, ensuring stability despite fluctuating gas compositions, which differentiates it from less flexible thermocatalytic methods used by some competitors.

Management Changes

Corporate Governance

Legal Proceedings

• **Schara litigation**: A putative class action complaint filed in May 2024 against LanzaTech (subsequently dismissed), AMCI Sponsor, and individual directors for purported damages from the Business Combination. A settlement was approved by the Court on March 4, 2026, and will be funded by the Company in April 2026.
• **FPA litigation**: LanzaTech filed suit against Vellar in July 2024 regarding alleged breach of the Forward Purchase Agreement (FPA) and sale of Recycled Shares. Vellar countersued. The parties agreed to a settlement in February 2026, involving a cash payment from LanzaTech to Vellar, and voluntary dismissal was granted on March 5, 2026.
• **Convertible Note Litigation**: Carbon Direct Capital commenced a lawsuit in May 2025, contending the mandatory conversion of the Convertible Note was invalid. The Supreme Court denied Carbon Direct Capital's requests for a temporary restraining order and preliminary injunction, and granted the Company's motion to dismiss the complaint on July 3, 2025. The Appellate Division affirmed the dismissal on January 27, 2026, and no further appeal was filed.
• **Delaware Court of Chancery lawsuit**: Carbon Direct Capital commenced a separate lawsuit in June 2025, alleging material misstatements or omissions in the proxy statement. The Court of Chancery denied Carbon Direct Capital's motion to expedite, and a notice of voluntary dismissal of the action was filed on August 5, 2025.

Related Party Transactions

• The company holds equity ownership in LanzaJet and Beijing Shougang LanzaTech Technology Co., Ltd (SGLT).
• Revenue from related parties, primarily from licensing, increased to $19.843 million in 2025 from $11.297 million in 2024.
• Revenue from engineering and other services from related parties decreased to $0.654 million in 2025 from $1.784 million in 2024.
• Accounts receivable from related parties were $2.281 million as of December 31, 2025, down from $2.452 million in 2024.
• Notes receivable from LanzaJet amounted to $5.789 million as of December 31, 2025.
• In December 2023, LanzaTech sold LanzaJet the right to utilize some of LanzaTech's completed engineering work for $2.0 million, recorded as a receivable, to be offset against future license fees.
• The company recognized $0.155 million in lease revenue in 2025 from an agreement to lease land to a subsidiary of LanzaJet.
• LanzaTech supplies SGLT with certain water-soluble organic compounds, small-size equipment, and consulting services, recognizing immaterial revenue from these transactions.

Stakeholder Impact

• **Shareholders**: Face significant dilution risk from the PIPE Warrant and potential future equity raises. Ownership is highly concentrated, potentially limiting trading activity and influence for other shareholders. No cash dividends are anticipated in the foreseeable future. The stock price is subject to volatility and delisting risk.
• **Employees**: Experienced a workforce reduction at the Skokie, Illinois location in 2025. Temporary capacity constraints in the finance organization due to turnover could impact workload and job security. Stock-based compensation plans are in place.
• **Customers/Partners**: Continued reliance on industry partners for growth, with potential for project delays due to government funding. Fluctuations in feedstock prices and regulatory changes could impact the cost and adoption of LanzaTech's technologies and products.
• **Creditors**: The Brookfield Loan maturity date was extended, and LanzaJet Note principal payments were deferred, providing more time for repayment. The LanzaJet Note Purchase Agreement permits up to $25.0 million in senior debt, which could affect the priority of existing LanzaJet Note holders.

Next Steps

• Remediate identified material weaknesses in internal control over financial reporting.
• Continue pursuing capital raising, partnership, or asset-related opportunities, and other strategic options to enhance liquidity.
• Advance projects in the first cohort, with the earliest targeted for operations in the first half of 2027.
• File a resale registration statement for the PIPE Warrant Shares within 60 business days following issuance.
• LanzaJet to continue commissioning, ramp-up, and sustained commercial operations at the Freedom Pines Biorefinery.
• LanzaJet to consummate additional closings of its current financing round.
• The company will fund the Schara litigation settlement in April 2026.
• A license agreement between LanzaTech and LanzaJet is in process and expected to be executed in 2026.

Key Dates

Recommendation

LanzaTech's explicit disclosure of "substantial doubt about our ability to continue as a going concern," coupled with a significant accumulated deficit and ongoing cash outflows from operations, signals severe financial instability. While the net loss decreased and revenue grew, the company remains highly dependent on future capital raises, which will likely result in further significant dilution for existing shareholders. The identified material weaknesses in internal controls add to the operational and financial reporting risks. Despite some positive operational developments and recent capital raises, the fundamental financial health and liquidity concerns present a high-risk investment profile, warranting a 'sell' recommendation for risk-averse investors.

Keywords

LanzaTech, Carbon Capture, Sustainable Aviation Fuel, SAF, Ethanol, Waste-to-Energy, Biorefining, Gas Fermentation, CarbonSmart, ESG, Renewable Fuels, Biotechnology, SEC 10-K, Financial Reporting, Going Concern, Dilution, Nasdaq, Clean Technology